Correction to: Real-World Safety of Intravitreal Bevacizumab and Ranibizumab Treatments for Retinal Diseases in Thailand: A Prospective Observational Study
Clin Drug Investig. 2019 Jan;39(1):115.
doi: 10.1007/s40261-019-00747-y.
1 Social and Administrative Pharmacy Excellence Research (SAPER) Unit, Department of Pharmacy, Faculty of Pharmacy, Mahidol University, 447 Sri-Ayuthaya Road, Rajathevi, Bangkok, 10400, Thailand.
2 Social and Administrative Pharmacy Excellence Research (SAPER) Unit, Department of Pharmacy, Faculty of Pharmacy, Mahidol University, 447 Sri-Ayuthaya Road, Rajathevi, Bangkok, 10400, Thailand. [email protected].
3 Health Intervention and Technology Assessment Program, Ministry of Public Health, Nonthaburi, Thailand.
4 Institute of Health and Wellbeing, University of Glasgow, Glasgow, UK.
5 Department of Ophthalmology, Khon Kaen University, Khon Kaen, Thailand.
6 Department of Statistics, Faculty of Science, Kasetsart University, Bangkok, Thailand.
7 Department of Ophthalmology, Faculty of Medicine, Rajavithi Hospital, Rangsit University, Bangkok, Thailand.
8 Mettapracharak Eye Institute, Mettapracharak (Wat Rai Khing) Hospital, Nakhon Pathom, Thailand.
9 Department of Ophthalmology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
10 Department of Ophthalmology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
11 Department of Ophthalmology, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
12 Department of Ophthalmology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
13 Department of Ophthalmology, Phramongkutklao Hospital, Phramongkutklao College of Medicine, Bangkok, Thailand.